The DOI matches its Crossref record.
Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?
Open accessAbstract
Public attention and debate recently have focused on access to treatment of acquired immunodeficiency syndrome (AIDS) in poor, severely affected countries, such as those in Africa. Whether patents on antiretroviral drugs in Africa are impeding access to lifesaving treatment for the 25 million Africans with human immunodeficiency virus infection is unknown. We studied the patent statuses of 15 antiretroviral drugs in 53 African countries. Using a survey method, we found that these antiretroviral drugs are patented in few African countries (median, 3; mode, 0) and that in countries where antiretroviral drug patents exist, generally only a small subset of antiretroviral drugs are patented (median and mode, 4). The observed scarcity of patents cannot be simply explained by a lack of patent laws because most African countries have offered patent protection for pharmaceuticals for many years. Furthermore, in this particular case, geographic patent coverage does not appear to correlate with antiretroviral treatment access in Africa, suggesting that patents and patent law are not a major barrier to treatment access in and of themselves. We conclude that a variety of de facto barriers are more responsible for impeding access to antiretroviral treatment, including but not limited to the poverty of African countries, the high cost of antiretroviral treatment, national regulatory requirements for medicines, tariffs and sales taxes, and, above all, a lack of sufficient international financial aid to fund antiretroviral treatment. We consider these findings in light of policies for enhancing antiretroviral treatment access in poor countries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAM
Pogge, T. W. (2005) · Metaphilosophy · doi:10.1111/j.1467-9973.2005.00362.x · Cited by 495
Sell, S. K., & Prakash, A. (2004) · International Studies Quarterly · doi:10.1111/j.0020-8833.2004.00295.x · Cited by 493
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Hoen, E. '., Berger, J., Calmy, A., & Moon, S. (2011) · Journal of the International AIDS Society · doi:10.1186/1758-2652-14-15 · Cited by 334
Pharmaceuticals and the Developing World
Kremer, M. (2002) · Journal of Economic Perspectives · doi:10.1257/089533002320950984 · Cited by 322
Metadata
- Authors
- Attaran, A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-10-17
- Volume
- 286
- Issue
- 15
- Pages
- 1886
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2171639414
- Cited by
- 169
- References
- 0
- FWCI
- 36.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa? https://app.cochat.ai/papers/10.1001/jama.286.15.1886
- The paper
- Attaran, A. (2001). Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa? JAMA. https://doi.org/10.1001/jama.286.15.1886
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.